Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years

Weimin Fan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6897-9452; OpenAlex author ID A5070413989. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. [Corrigendum] Gemcitabine combined with an engineered oncolytic vaccinia virus exhibits a synergistic suppressive effect on the tumor growth of pancreatic canc… First author DOI 10.3892/or.2025.9013↗
  2. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer. Last author DOI 10.18632/aging.101933↗
  3. Gemcitabine combined with an engineered oncolytic vaccinia virus exhibits a synergistic suppressive effect on the tumor growth of pancreatic cancer. First author DOI 10.3892/or.2018.6817↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shibing Wang · 2 shared papers, 2019–2026 · strength 0.42
  2. Wanyuan Chen · 2 shared papers, 2019–2026 · strength 0.42
  3. Wenlong Wang · 1 shared paper, 2019 · strength 0.11
  4. Weiyang Lou · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.